This month we’re featuring our Senior Research Fellow Dr Daniel Hayes. Daniel is an interdisciplinary mixed-methods researcher, specialising in mental health and social prescribing for young people. He is currently leading our Wellbeing While Waiting project. Read on to learn more about the phases and aims of the project as well as the barriers children and young people face in accessing social prescribing and the role of a link worker.
Q: Can you tell me about Wellbeing While Waiting and what the aims of this project are?
D: The aims of Wellbeing While Waiting are to understand if social prescribing can help young people whilst they wait for treatment within child and adolescent mental health services (CAMHS).
We know that social prescribing can help with mental health and wellbeing, there’s good evidence of that in adult populations and promising evidence of that in youth populations. But, to date, it’s been mainly based in primary care (GP surgeries). At the same time, what we also know is that whilst young people are waiting for treatment within CAMHS, particularly post the Covid-19 pandemic, wait times for treatment are getting longer. So, with Wellbeing While Waiting we want to understand if social prescribing can be used in secondary care for young people whilst they wait for treatment and what benefits, if any, this has for this group. For example, stopping deterioration or whether some young people come off the waiting lists as they feel they no longer need treatment.
Q: What phase is the project in at the moment?
D: The project is split into 3 phases: the first is the pathway co-development phase. We have completed that with the majority of the 10 CAMHS sites involved. We’re just moving into phase 2 (the research phase) where we are recruiting the control group prior to the social prescribing pathways being rolled out and used in CAMHS.
Q: Why is social prescribing an important pathway for children and young people?
D: The prevalence of mental ill health for children and young people is sky-rocketing in the UK (as well as internationally) and we need novel up and down-stream approaches to help address this. Importantly, social prescribing can be used as both an up and downstream intervention (i.e. early intervention or as part of treatment). However, it’s important to understand that social prescribing is just one potential tool to help address the social determinants of health and help with mental health and wellbeing.
Social prescribing, like other concepts such as self-management, and shared decision making, are all very much about the personalisation of care for patients, in this case, young people. It’s not just about trying to find something else for young people to do, it’s much more about understanding what the young person wants and needs and how this would fit with them and their lifestyle. Maybe some young people don’t feel comfortable with certain types of support or treatment or would prefer to explore other avenues. Social prescribing is about finding out a young persons unique values, gifts and talents and providing support to help them improve their mental health and wellbeing via addressing the social determinants of health.